Active broad market exchange-traded funds at mid-day:
SPDR S&P 500 (
iShares MSCI Emerging Markets Index (
SPDR Gold Trust (
Financial Select Sector SPDR (
): -0.75%, near its 52-week high
iShares Russell 2000 Index (
Broad Market Indicators
Broad-market exchange-traded funds, including SPY, IWM, IVV and
others, continued to be weaker. Actively traded PowerShares QQQ
(QQQ) was down 0.26%.
U.S. stocks extended their losses into the session's half,
logging further losses following the report that the University of
Michigan-Thomson Reuters gauge on consumer sentiment dropped to
72.3 - its lowest reading since July, and missing the forecast of
79.3. Earlier, retail sales for March were reported to have
declined to an adjusted 0.4% - its biggest decline since June; ex
auto, retail sales also slipped 0.4%.
Analysts had pegged retail sales to remain unchanged, according
to Briefing.com. Meanwhile, PPI for March fell 0.6%, a wider
decline than the expected decrease of 0.1%. Core PPI rose 0.2%,
versus the forecasts of a 0.1% growth. Business inventories for
February rose 0.1% but missed the estimate of 0.4% increase. Fed
Chairman Ben Bernanke spoke at a press conference, discussing the
creation of resilient communities, but did not tackle monetary
Winners and Losers
were in the red at mid-day: Technology Select Sector SPDR ETF
(XLK), down 0.85%; iShares Dow Jones US Technology ETF (IYW), down
0.89%; iShares S&P North American Technology ETF (IGM), down
0.84%; and iShares S&P North American Technology-Software Index
(IGV), down 0.57%.
Among semiconductor ETFs, SPDR S&P Semiconductor (XSD) was
down 0.77% and Semiconductor Sector Index Fund (SOXX) was down
SPDR S&P International Technology Sector ETF (IPK) was down
In sector news, Infosys Ltd. (INFY) slipped further, down 20.5%
at mid-day. The company reported that fourth quarter 2013 EPS was
$0.78 versus consensus estimate of $0.74. Revenues totaled $2
billion. Year-ago earnings per share was 81 cents, with revenues of
$1.8 billion. For the fiscal year ending March 31, 2014, revenues
are expected to grow 6% to 10%. The company also discontinued EPS
Dow Jones U.S. Energy Fund (IYE) was down 1.64%. Energy Select
Sector SPDR (XLE) was down 1.73%.
In sector news, CONSOL Energy (CNX) reversed and was down 2.66%
at last check. The coal and natural gas company reported that its
Coal Division produced 14.8 million tons for Q1 of 2013, including
1.3 million tons of low-vol coking coal from the company's Buchanan
Mine. Both figures exceeded guidance as production surged to meet
stronger-than-expected export markets.
CNX's Gas Division produced 39.2 Bcfe for Q1 or 4% more than the
37.7 Bcfe produced in the comparable quarter last year. This
represented a decline in production of 6% compared to the prior
quarter. For Q2, the company expects total coal production to be
between 13.25 - 13.75 million tons. Buchanan Mine's Q2 production
is expected to be between 0.9 - 1.0 million tons.
Gas production, net to CNX, is expected to be 38 Bcfe - 40 Bcfe,
or relatively flat compared with the 39.2 Bcfe produced in Q1 of
2013. For FY13, total coal production guidance is 55.5 - 57.5
million tons. Gas production is projected to be 170 Bcfe - 180
Bcfe, net to CNX. Buchanan Mine's annual production guidance is now
estimated at 4.0 - 4.2 million tons.
Crude was down 2.87%; natural gas was up 2.05%. United States
Oil Fund (USO) was down 2.60%. United States Natural Gas Fund (UNG)
was up 1.77%.
Gold was down 3.73%, sinking to a new 52-week low of $1491.
Silver saw sharp losses as well, and was down 4.72%, hitting a new
52-week low of $25.97. Among rare metal funds, SPDR Gold Trust (
) was down 3.53%, with a 52-week low of $144.34; iShares Silver
Trust (SLV) was down 4.19%, also with a new 52-week low of
Healthcare ETFs were mixed but trading at the higher end of
their 52-week ranges: Health Care SPDR (XLV), up 0.05%; Vanguard
Health Care ETF (VHT), down 0.01%; and iShares Dow Jones US
Healthcare (IYH), up 0.03%. Biotech ETF iShares NASDAQ
Biotechnology Index (IBB) was up 0.40%, with a new 52-week high of
In corporate news, Warner Chilcott (WCRX) was up 4.51% after
earlier announcing that the FDA approved a 200-mg dosage of DORYX
Delayed-Release Tablets. DORYX Delayed-Release Tablets are a
tetracycline-class oral antibiotic. The company anticipates that it
will commercially launch DORYX Delayed-Release 200-mg Tablets in
Consumer ETFs were mixed but near their 52-week highs: Consumer
Staples Select Sector SPDR (XLP), up 0.17%; iShares Dow Jones US
Consumer Goods (IYK), down 0.13%; and Vanguard Consumer Staples ETF
(VDC), up 0.20%.
In sector news, Chuy's Holdings (CHUY) was down 4.81% after
pricing its secondary public offering of common stock at $33 a
share, a discount to the $34.17 closing price on Thursday. Existing
shareholders are selling a total of 3 million shares in the
offering, with an option for underwriters to take a further 450,000
Power Play -
ETFs and stocks in the space continued to see active trade
following the earnings results of major banks JPMorgan Chase (JPM)
and Wells Fargo (WFC). Select Financial Sector SPDRs (
) was down 0.75%, but still near its 52-week high. Direxion Daily
Financial Bull 3X shares (FAS) was down 2.32%. Its bearish
counterpart, FAZ, was up 2.35%.
Among financial stocks, Wells Fargo (WFC) was steady lower, down
1.76% after it reported Q1 earnings of $0.92, better than the
analyst consensus of $0.89 per share on Capital IQ. Revenue was
$21.26 bln, shy of the Street view of $21.4 bln. Both loans and
core deposits were up from year ago levels. According to Bloomberg
News, shares are feeling pressure after WFC's interest margin for
the quarter missed estimates.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.